New York 2025-2026 Regular Session

New York Assembly Bill A03283

Introduced
1/27/25  

Caption

Requires gene synthesis providers and manufacturers of gene synthesis equipment to operate in accordance with international gene synthesis consortium protocols.

Companion Bills

No companion bills found.

Previously Filed As

NY A10095

Establishes minimum protocol requirements for gene synthesis providers and manufacturers of gene synthesis equipment; requires such providers and manufacturers to operate in accordance with international gene synthesis consortium protocols.

NY S00595

Criminalizes the sale, use and possession of synthetic drugs; provides various definitions for types of synthetic drugs.

NY A00197

Relates to synthetic cannabinoids, synthetic cannabinoid analog and substituted cathinones; prohibits the production and sale thereof.

NY A00443

Provides the New York power authority with the right of first offer and refusal for acquiring any renewable generation facility, renewable energy generation project and any power or energy created by a renewable generation facility or renewable energy generation project.

NY S02583

Provides the New York power authority with the right of first offer and refusal for acquiring any renewable generation facility, renewable energy generation project and any power or energy created by a renewable generation facility or renewable energy generation project.

NY S06638

Enacts the "political artificial intelligence disclaimer (PAID) act"; requires political communications that use synthetic media to disclose that they were created with the assistance of artificial intelligence; requires committees that use synthetic media to maintain records of such usage.

NY A07106

Enacts the "political artificial intelligence disclaimer (PAID) act"; requires political communications that use synthetic media to disclose that they were created with the assistance of artificial intelligence; requires committees that use synthetic media to maintain records of such usage.

NY A00895

Enacts the manufacturer disclosure and transparency act requiring prescription drug manufacturers to notify the attorney general of arrangements between pharmaceutical manufacturers resulting in the delay of the introduction of generic medications.

NY S03518

Enacts the manufacturer disclosure and transparency act requiring prescription drug manufacturers to notify the attorney general of arrangements between pharmaceutical manufacturers resulting in the delay of the introduction of generic medications.

NY S02689

Enacts the "Renewable Capitol act"; requires the office of general services, in consultation with the power authority of the state of New York, to ensure that all operations that power, heat or cool the empire state plaza complex shall entirely use renewable energy systems; requires the office of general services to establish an advisory committee to advise the office of general services on the preparation, design and content of a plan for the use of renewable energy systems.

Similar Bills

No similar bills found.